Literature DB >> 27202246

Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece.

V Fragoulakis1, P Papakostas2, G Pentheroudakis3, C Dervenis4, N Maniadakis1.   

Abstract

Entities:  

Year:  2014        PMID： 27202246     DOI： 10.1016/j.jval.2014.08.2263

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

Review 1.  Dilemma of first line regimens in metastatic pancreatic adenocarcinoma.

Authors:  Marwan Ghosn; Tony Ibrahim; Tarek Assi; Elie El Rassy; Hampig Raphael Kourie; Joseph Kattan
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.